These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

667 related items for PubMed ID: 19667556

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Established and potential risk factors for Clostridum difficile infection.
    Vaishnavi C.
    Indian J Med Microbiol; 2009; 27(4):289-300. PubMed ID: 19736396
    [Abstract] [Full Text] [Related]

  • 3. [Epidemiology of Clostridium difficile infection].
    Szczesny A, Martirosian G.
    Przegl Epidemiol; 2002; 56(1):49-56. PubMed ID: 12150067
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Infection control measures to limit the spread of Clostridium difficile.
    Vonberg RP, Kuijper EJ, Wilcox MH, Barbut F, Tüll P, Gastmeier P, European C difficile-Infection Control Group, European Centre for Disease Prevention and Control (ECDC), van den Broek PJ, Colville A, Coignard B, Daha T, Debast S, Duerden BI, van den Hof S, van der Kooi T, Maarleveld HJ, Nagy E, Notermans DW, O'Driscoll J, Patel B, Stone S, Wiuff C.
    Clin Microbiol Infect; 2008 May; 14 Suppl 5():2-20. PubMed ID: 18412710
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Update on the changing epidemiology of Clostridium difficile-associated disease.
    McFarland LV.
    Nat Clin Pract Gastroenterol Hepatol; 2008 Jan; 5(1):40-8. PubMed ID: 18174906
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Treatment strategies for recurrent and refractory Clostridium difficile-associated diarrhea.
    Stepan C, Surawicz CM.
    Expert Rev Gastroenterol Hepatol; 2007 Dec; 1(2):295-305. PubMed ID: 19072422
    [Abstract] [Full Text] [Related]

  • 11. New advances in Clostridium difficile infection: changing epidemiology, diagnosis, treatment and control.
    DuPont HL, Garey K, Caeiro JP, Jiang ZD.
    Curr Opin Infect Dis; 2008 Oct; 21(5):500-7. PubMed ID: 18725800
    [Abstract] [Full Text] [Related]

  • 12. Clostridium difficile-associated diarrhea: risk factors, diagnostic methods, and treatment.
    Oldfield EC.
    Rev Gastroenterol Disord; 2004 Oct; 4(4):186-95. PubMed ID: 15580153
    [Abstract] [Full Text] [Related]

  • 13. Clostridium difficile: changing epidemiology and new treatment options.
    Kuijper EJ, van Dissel JT, Wilcox MH.
    Curr Opin Infect Dis; 2007 Aug; 20(4):376-83. PubMed ID: 17609596
    [Abstract] [Full Text] [Related]

  • 14. Emergence of Clostridium difficile-associated disease in North America and Europe.
    Kuijper EJ, Coignard B, Tüll P, ESCMID Study Group for Clostridium difficile, EU Member States, European Centre for Disease Prevention and Control.
    Clin Microbiol Infect; 2006 Oct; 12 Suppl 6():2-18. PubMed ID: 16965399
    [Abstract] [Full Text] [Related]

  • 15. The use of probiotics in the prevention and treatment of antibiotic-associated diarrhea with special interest in Clostridium difficile-associated diarrhea.
    Rohde CL, Bartolini V, Jones N.
    Nutr Clin Pract; 2009 Oct; 24(1):33-40. PubMed ID: 19244146
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Epidemiology, clinical manifestations, and outcome of Clostridium difficile-associated diarrhea.
    Anand A, Bashey B, Mir T, Glatt AE.
    Am J Gastroenterol; 1994 Apr; 89(4):519-23. PubMed ID: 8147353
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 34.